Original document(14 pages)  中文版
    The invention relates to a drug used to accelerate the growth of pigling and improve its immunity, and relative production. Wherein, it is formed by PLGA microball that packing anterior pituitary growth hormone release hormone expression particle pCMV-Rep-GHRH; via ejecting said PLGA microball particles pCMV-Rep-GHRH into female pig, to express GHRH and improve the GH level, it can accelerate the growth of pigling and improve its immunity.
Application Number
申请号		 200610017214 Application Date
申请日		 2006.09.29
Title 名称 Medicine for promoting pigling growth and improving pigling immunity and preparing method thereof
Publication Number
公开号		 1927403 Publication Date
公开日		 2007.03.14
Approval Pub. Date Granted Pub. Date
International Classification 分类号 A61K48/00;A61K9/30;A61P5/20;A61P37/02
Applicant(s) Name
申请人		 Zhang Yongliang
Address 地址
Inventor(s) Name 发明人
Attorney & Agent 代理人 chenhong wei

  
Cardioactivator electrode duct bended along esophageal direction
Medicine for curing burn and scald
Non-cyanide electroplating process for zinc alloy die casting
Artificial traction fiber protein gene and cascade method and expression thereof
Method for preparing antler polypeptide and medicine with the antler polypeptide as main active component
Anthraquinone ramification of rhubarb, preparing method and combination of medication by using the ramification as active ingredient
Multiple copy expression box recombinant yeast expression plasmid quick construction method
Method and device for remote looking after baby
GRF��1-32��and SS-HbsAg fusion gene combination and its constructed expression system and pharmaceutical preparation
Use of ginseng fruit extract for preparing anti-anoxia medicine
Note:All patent data come from State Intellectual Property Office of the People's Republic of China. If there were discrepancies between here and the State Intellectual Property office, the later is more accurate. The patent data is only for public exchange and learning purposes. We are not responsible for the adverse consequences with unverified use of the data.